Given that we examined the effect of exogenous addition of CD24 to a low-expressing neuroblastoma cell line (SK-N-AS), we also examined the impact of the loss of CD24 in a highly expressing neuroblastoma cell line. The gene discussed is CD24; the disease is neuroblastoma.